RESUMEN
Tetherin/BST-2 is an antiviral protein that blocks the release of enveloped viral particles by linking them to the membrane of producing cells. At first, BST-2 genes were described only in humans and other mammals. Recent work identified BST-2 orthologs in nonmammalian vertebrates, including birds. Here, we identify the BST-2 sequence in domestic chicken (Gallus gallus) for the first time and demonstrate its activity against avian sarcoma and leukosis virus (ASLV). We generated a BST-2 knockout in chicken cells and showed that BST-2 is a major determinant of an interferon-induced block of ASLV release. Ectopic expression of chicken BST-2 blocks the release of ASLV in chicken cells and of human immunodeficiency virus type 1 (HIV-1) in human cells. Using metabolic labeling and pulse-chase analysis of HIV-1 Gag proteins, we verified that chicken BST-2 blocks the virus at the release stage. Furthermore, we describe BST-2 orthologs in multiple avian species from 12 avian orders. Previously, some of these species were reported to lack BST-2, highlighting the difficulty of identifying sequences of this extremely variable gene. We analyzed BST-2 genes in the avian orders Galliformes and Passeriformes and showed that they evolve under positive selection. This indicates that avian BST-2 is involved in host-virus evolutionary arms races and suggests that BST-2 antagonists exist in some avian viruses. In summary, we show that chicken BST-2 has the potential to act as a restriction factor against ASLV. Characterizing the interaction of avian BST-2 with avian viruses is important in understanding innate antiviral defenses in birds.IMPORTANCE Birds are important hosts of viruses that have the potential to cause zoonotic infections in humans. However, only a few antiviral genes (called viral restriction factors) have been described in birds, mostly because birds lack counterparts of highly studied mammalian restriction factors. Tetherin/BST-2 is a restriction factor, originally described in humans, that blocks the release of newly formed virus particles from infected cells. Recent work identified BST-2 in nonmammalian vertebrate species, including birds. Here, we report the BST-2 sequence in domestic chicken and describe its antiviral activity against a prototypical avian retrovirus, avian sarcoma and leukosis virus (ASLV). We also identify BST-2 genes in multiple avian species and show that they evolve rapidly in birds, which is an important indication of their relevance for antiviral defense. Analysis of avian BST-2 genes will shed light on defense mechanisms against avian viral pathogens.
Asunto(s)
Proteínas Aviares/inmunología , Virus del Sarcoma Aviar/inmunología , Antígeno 2 del Estroma de la Médula Ósea/inmunología , Evolución Molecular , Galliformes/inmunología , Sarcoma Aviar/inmunología , Secuencia de Aminoácidos , Animales , Proteínas Aviares/genética , Virus del Sarcoma Aviar/genética , Virus del Sarcoma Aviar/patogenicidad , Antígeno 2 del Estroma de la Médula Ósea/genética , Línea Celular , Fibroblastos/inmunología , Fibroblastos/virología , Galliformes/genética , Galliformes/virología , Regulación de la Expresión Génica , Células HEK293 , VIH-1/genética , VIH-1/inmunología , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Passeriformes/genética , Passeriformes/inmunología , Passeriformes/virología , Sarcoma Aviar/genética , Sarcoma Aviar/virología , Selección Genética , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transducción de Señal , Liberación del Virus , Replicación Viral , Productos del Gen gag del Virus de la Inmunodeficiencia Humana/genética , Productos del Gen gag del Virus de la Inmunodeficiencia Humana/inmunologíaRESUMEN
The present study determines the cytokine gene expression in chickens following RSV-A infection, using RT-qPCR. In susceptible chickens tumors progressed to fulminating metastatic tumors while it regressed in regressors chickens and some resistant non-responder chickens did not respond to RSV-A infection and thus did not develop tumors at all. The in vivo expression of pro-inflammatory cytokines, Th1 cytokines and Th2 cytokines was determined at the primary site of infection, as well as in different organs of progressor, regressor and non-responder chicks at different time intervals. Our results indicated a significant upregulation of the pro-inflammatory cytokines, IL-6 and IL-8, in all the organs of progressor chicks, while they were significantly lower in regressor and non-responder chicks. The expression of the Th1 cytokines IFN-γ and TNF-α was low in all of the organs of the progressor group, except that in spleen. In contrast, regressor and non-responder groups showed high expression of IFN-γ and TNF-α. Further, there was an early upregulation of the expression of the Th2 cytokine, IL-10, TGF-ß and GM-CSF, in all of the organs of progressors as compared to uninfected control.
Asunto(s)
Citocinas/inmunología , Virus del Sarcoma de Rous/inmunología , Sarcoma Aviar/inmunología , Células TH1/inmunología , Células Th2/inmunología , Animales , Pollos , Citocinas/genética , Expresión Génica/inmunología , Interacciones Huésped-Patógeno/inmunología , Mediadores de Inflamación/inmunología , Mediadores de Inflamación/metabolismo , Virus del Sarcoma de Rous/fisiología , Sarcoma Aviar/genética , Sarcoma Aviar/virología , Células TH1/metabolismo , Células TH1/virología , Células Th2/metabolismo , Células Th2/virología , Regulación hacia Arriba/inmunologíaRESUMEN
We investigated the impact of haplotype of major histocompatibility complex (MHC)-B on the outcome of infection of Synthetic Dam Line (SDL) broiler strain with Rous Sarcoma Virus (RSV). Genomic analysis of MHC-B haplotypes, revealed a total of 12 known standard haplotypes that constituted to twenty-five different genotypes and one new haplotype of 217 bp size, designated BX. The inoculation of RSV-A in SDL chicks resulted in the development of tumors of progressive or regressive phenotypes with varying tumor profile index (TPI). Haplotypes B2, B21 and B22had low TPI scores (1 or 2) with less mortality and were resistant to RSV-A tumor. The haplotypes B13, B13.1., B15, B15.1. and B15.2. had significantly higher TPI scores (5 or 6), indicating a susceptibility to RSV-A. The genotype, Bx /Bx, had a mean TPI score of 3.67 ± 1.33, which was closer to the resistant haplotype. Sequence analysis of the new haplotype (BX) revealed 99.5% similarity with B2 haplotype. Metastases was observed in 44% of chicks and comprised of mixed fibrosarcoma and myxosarcoma.
Asunto(s)
Pollos/inmunología , Complejo Mayor de Histocompatibilidad , Virus del Sarcoma de Rous/inmunología , Sarcoma Aviar/inmunología , Animales , Haplotipos , Sarcoma Aviar/patologíaRESUMEN
Systems of antigen delivery into antigen-presenting cells represent an important novel strategy in chicken vaccine development. In this study, we verified the ability of Rous sarcoma virus (RSV) antigens fused with streptavidin to be targeted by specific biotinylated monoclonal antibody (anti-CD205) into dendritic cells and induce virus-specific protective immunity. The method was tested in four congenic lines of chickens that are either resistant or susceptible to the progressive growth of RSV-induced tumors. Our analyses confirmed that the biot-anti-CD205-SA-FITC complex was internalized by chicken splenocytes. In the cytokine expression profile, several significant differences were evident between RSV-challenged progressor and regressor chicken lines. A significant up-regulation of IL-2, IL-12, IL-15, and IL-18 expression was detected in immunized chickens of both regressor and progressor groups. Of these cytokines, IL-2 and IL-12 were most up-regulated 14 days post-challenge (dpc), while IL-15 and IL-18 were most up-regulated at 28 dpc. On the contrary, IL-10 expression was significantly down-regulated in all immunized groups of progressor chickens at 14 dpc. We detected significant up-regulation of IL-17 in the group of immunized progressors. LITAF down-regulation with iNOS up-regulation was especially observed in the progressor group of immunized chickens that developed large tumors. Based on the increased expression of cytokines specific for activated dendritic cells, we conclude that our system is able to induce partial stimulation of specific cell types involved in cell-mediated immunity.
Asunto(s)
Antígenos Virales/inmunología , Pollos/virología , Citocinas/fisiología , Células Dendríticas/inmunología , Virus del Sarcoma de Rous/inmunología , Sarcoma Aviar/prevención & control , Vacunas Virales/inmunología , Animales , Animales Congénicos/inmunología , Animales Congénicos/virología , Anticuerpos Biespecíficos/inmunología , Antígenos CD/inmunología , Pollos/inmunología , Células Dendríticas/virología , Inmunidad Celular/inmunología , Lectinas Tipo C/inmunología , Antígenos de Histocompatibilidad Menor/inmunología , Receptores de Superficie Celular/inmunología , Sarcoma Aviar/inmunologíaRESUMEN
OBJECTIVE: To prepare anti-fps mono-specific serum, and detect the fps antigen in tumors induced by acute transforming avian leukosis/sarcoma virus containing v-fps oncogene. METHODS: Two part of v-fps gene was amplified by RT-PCR using the Fu-J viral RNA as the template. Mono-specific serum was prepared by immuning Kunming white mouse with both two recombinant infusion proteins expressed by the prokaryotic expression system. Indirect immunofluorescent assay was used to detect fps antigen in tumor tissue suspension cells and CEF infected by sarcoma supernatant. Immunohistochemical method was used to detect fps antigen in tumor tissue. RESULTS: The mouse mono-specific serum was specific as it had no cross reaction with classical ALV-J strains. The result reveals that the tumor tissue suspension cells, the CEF infected by sarcoma supernatant, and the slice immunohistochemistry of the sarcoma showed positive results. CONCLUSION: The anti-fps mono-specific serum was prepared, and the detection method was established, which laid the foundation for the study of viral biological characteristics and mechanism of tumourgenesis of acute transforming avian leukosis/sarcoma virus containing v-fps oncogene.
Asunto(s)
Virus de la Leucosis Aviar/inmunología , Virus del Sarcoma Aviar/inmunología , Pollos , Fibrosarcoma/inmunología , Enfermedades de las Aves de Corral/inmunología , Proteínas Proto-Oncogénicas c-fes/inmunología , Animales , Anticuerpos Antivirales/inmunología , Especificidad de Anticuerpos , Antígenos de Neoplasias/genética , Antígenos de Neoplasias/inmunología , Leucosis Aviar/inmunología , Leucosis Aviar/virología , Transformación Celular Neoplásica , Fibrosarcoma/virología , Ratones , Enfermedades de las Aves de Corral/virología , Proteínas Proto-Oncogénicas c-fes/genética , ARN Viral/genética , Sarcoma Aviar/inmunología , Sarcoma Aviar/virología , Organismos Libres de Patógenos EspecíficosRESUMEN
The chicken major histocompatibility complex (MHC-B locus) has a strong association with resistance and susceptibility to numerous diseases. We have found a B haplotype designated WLA that associated with the regression of tumours caused by Rous sarcoma virus J strain (RSV-J). Haplotype WLA was identical to the regressive B6 haplotype when partial genotyping was performed (Poultry Science, 89, 2010, 651). We then constructed a bacterial artificial chromosome (BAC) library from a WLA homozygote chicken to evaluate the structure of this regression haplotype and compared it to those of the B6 haplotype. Comparison between WLA and B6 above 59 kb within the 167 kb, including 14 genes from BG1 to BF2, revealed 75 SNPs and 14 indels. However, several genes were identical between WLA and B6, including the BF1 and BF2 genes, which encode a class I molecule previously suggested to be related to the regression phenotype. The BLB2 gene encoding the MHC class II beta chain showed the greatest diversity, with 19 non-synonymous SNPs. A comparison of WLA and B6 haplotpyes that are associated with tumour regression and RIRa and B24 haplotypes associated with tumour progression suggests that DMA1, DMA2, BRD2, TAPBP and BLB2 genes are not involved in the intensity of RSV J tumour regression.
Asunto(s)
Pollos/genética , Complejo Mayor de Histocompatibilidad/genética , Sarcoma Aviar/genética , Animales , Mapeo Cromosómico , Cromosomas Artificiales Bacterianos , Marcadores Genéticos , Biblioteca Genómica , Genotipo , Haplotipos/genética , Haplotipos/inmunología , Mutación INDEL , Reacción en Cadena de la Polimerasa , Polimorfismo de Nucleótido Simple , Virus del Sarcoma de Rous/inmunología , Sarcoma Aviar/inmunologíaRESUMEN
The chicken MHC-B locus affects the response to several strains of Rous sarcoma virus (RSV). We evaluated the association between haplotypes of the MHC-B locus and responses to the J strain of RSV by using an F(2) experimental resource family constructed with tumor-regressive (White Leghorn) and tumor-progressive (Rhode Island Red) chickens. The MHC-B haplotypes were determined by genotyping of the microsatellite marker LEI0258 and MHC-B locus class I alpha chain 2 (BF2). Two haplotypes in the resource family, one associated with tumor regression and one with progression, were defined by these 2 markers. To discriminate more precisely the regressive haplotype in this family, we further developed 35 SNP markers at the MHC-B locus. Information on the haplotypes revealed here should be useful for identifying chickens with regression and progression phenotypes of J-strain RSV-induced tumors.
Asunto(s)
Pollos/genética , Complejo Mayor de Histocompatibilidad/genética , Sarcoma Aviar/genética , Animales , Mapeo Cromosómico , Cartilla de ADN , Marcadores Genéticos , Genotipo , Haplotipos/genética , Haplotipos/inmunología , Polimorfismo de Nucleótido Simple , Virus del Sarcoma de Rous/inmunología , Sarcoma Aviar/inmunologíaRESUMEN
A line of research beginning in the early 1960s with the observation that West Nile virus and, later, several strains of rabies virus could inhibit the development of the Rous sarcoma virus-induced tumor in the wing-web of chicken (a "sarcoma-blockade") eventually culminated in the characterization of a 14-kDa circulating anti-sarcoma and anti-viral activity christened "plasma factor" (PF) which, unlike the interferons, inhibited the replication of diverse RNA-containing viruses, but not of any DNA-containing viruses. The possibility that this 14 kDa protein represented a novel antiviral cytokine has been strengthened by analysis of partial amino acid sequencing data which suggest that this 14-kDa cytokine may correspond to the 127-amino acid-long chicken YB2-like protein (Locus: XP_423576) deduced very recently from the genomic sequencing of chicken. Biologically, proteins of the Y-box family (such as chicken YB1 and YB2) not only bind DNA and thus regulate transcription but also bind single-stranded RNA in a sequence-specific and reversible manner, repress viral RNA translation, inhibit retroviral transformation of chicken fibroblasts, and are known to regulate transcription of human immunodeficiency virus and hepatitis B virus. Taken together, the available data point to a novel anti-viral cytokine with a novel mechanism of action.
Asunto(s)
Proteínas Aviares/fisiología , Citocinas/fisiología , Proteínas de Unión al ADN/fisiología , Sarcoma Aviar/fisiopatología , Factores de Transcripción/fisiología , Secuencia de Aminoácidos , Animales , Proteínas Aviares/genética , Pollos , Proteínas de Unión al ADN/genética , Datos de Secuencia Molecular , Virus de la Rabia/patogenicidad , Sarcoma Aviar/inmunología , Sarcoma Aviar/prevención & control , Homología de Secuencia de Aminoácido , Factores de Transcripción/genética , Interferencia Viral , Virus del Nilo Occidental/patogenicidadRESUMEN
The subgroup A to E avian sarcoma and leukosis viruses (ASLVs) are highly related and are thought to have evolved from a common ancestor. These viruses use distinct cell surface proteins as receptors to gain entry into avian cells. Chickens have evolved resistance to infection by the ASLVs. We have identified the mutations responsible for the block to virus entry in chicken lines resistant to infection by subgroup A ASLVs [ASLV(A)]. The tva genetic locus determines the susceptibility of chicken cells to ASLV(A) viruses. In quail, the ASLV(A) susceptibility allele tva(s) encodes two forms of the Tva receptor; these proteins are translated from alternatively spliced mRNAs. The normal cellular function of the Tva receptor is unknown; however, the extracellular domain contains a 40-amino-acid, cysteine-rich region that is homologous to the ligand binding region of the low-density lipoprotein receptor (LDLR) proteins. The chicken tva(s) cDNAs had not yet been fully characterized; we cloned the chicken tva cDNAs from two lines of subgroup A-susceptible chickens, line H6 and line 0. Two types of chicken tva(s) cDNAs were obtained. These cDNAs encode a longer and shorter form of the Tva receptor homologous to the Tva forms in quail. Two different defects were identified in cDNAs cloned from two different ASLV(A)-resistant inbred chickens, line C and line 7(2). Line C tva(r) contains a single base pair substitution, resulting in a cysteine-to-tryptophan change in the LDLR-like region of Tva. This mutation drastically reduces the binding affinity of Tva(R) for the ASLV(A) envelope glycoproteins. Line 7(2) tva(r2) contains a 4-bp insertion in exon 1 that causes a change in the reading frame, which blocks expression of the Tva receptor.
Asunto(s)
Virus de la Leucosis Aviar/patogenicidad , Virus del Sarcoma Aviar/patogenicidad , Pollos/inmunología , Mutación , Receptores Virales/genética , Secuencia de Aminoácidos , Animales , Leucosis Aviar/inmunología , Leucosis Aviar/virología , Virus de la Leucosis Aviar/metabolismo , Proteínas Aviares , Virus del Sarcoma Aviar/metabolismo , Secuencia de Bases , Células Cultivadas , Embrión de Pollo , Pollos/virología , Datos de Secuencia Molecular , Codorniz , Receptores Virales/química , Receptores Virales/metabolismo , Sarcoma Aviar/inmunología , Sarcoma Aviar/virología , Análisis de Secuencia de ADNRESUMEN
The formation of a provisional extracellular matrix represents an important step during tumor growth and angiogenesis. Proteins that participate in this process become activated and undergo conformational changes that expose biologically active cryptic sites. Activated matrix proteins express epitopes not found on their native counterparts. We hypothesized that these epitopes may have a restricted tissue distribution, rendering them suitable targets for therapeutic human monoclonal antibodies (huMabs). In this study, we exploited phage antibody display technology and subtractive phage selection to generate human monoclonal antibody fragments that discriminate between the activated and native conformation of the extracellular matrix protein vitronectin. One of the selected antibody fragments, scFv VN18, was used to construct a fully human IgG/kappa monoclonal antibody with an affinity of 9.3 nM. In immunohistochemical analysis, scFv and huMab VN18 recognized activated vitronectin in tumor tissues, whereas hardly any activated vitronectin was detectable in normal tissues. Iodine 123-radiolabeled huMabVN18 was shown to target to Rous sarcoma virus-induced tumors in chickens, an animal model in which the epitope for huMab VN18 is exposed during tumor development. Our results establish activated vitronectin as a potential target for tumor therapy in humans.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Virus del Sarcoma Aviar/patogenicidad , Enfermedades de las Aves de Corral/terapia , Sarcoma Aviar/terapia , Vitronectina/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Sitios de Unión de Anticuerpos , Pollos , Neoplasias del Colon/inmunología , Neoplasias del Colon/terapia , Ensayo de Inmunoadsorción Enzimática , Mapeo Epitopo , Humanos , Fragmentos de Inmunoglobulinas/inmunología , Región Variable de Inmunoglobulina , Radioisótopos de Yodo , Melanoma Experimental/inmunología , Melanoma Experimental/terapia , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Desnudos , Fragmentos de Péptidos/inmunología , Biblioteca de Péptidos , Enfermedades de las Aves de Corral/diagnóstico por imagen , Enfermedades de las Aves de Corral/inmunología , Conformación Proteica , Radioinmunodetección , Sarcoma Aviar/diagnóstico por imagen , Sarcoma Aviar/inmunologíaRESUMEN
The chicken major histocompatibility (B) complex (MHC) affects disease outcome significantly. One of the best characterized systems of MHC control is the response to the oncogenic retrovirus, Rous sarcoma virus (RSV). Genetic selection altered the tumor growth pattern, either regressively or progressively, with the data suggesting control by one or a few loci. Particular MHC genotypes determine RSV tumor regression or progression indicating the crucial B complex role in Rous sarcoma outcome. Analysis of inbred lines, their crosses, congenic lines, and noninbred populations has revealed the anti-RSV response of many B complex haplotypes. Tumor growth disparity among lines identical at the MHC but differing in their background genes suggested a non-MHC gene contribution to tumor fate. Genetic complementation in tumor growth has also been demonstrated for MHC and non-MHC genes. RSV tumor expansion reflects both tumor cell proliferation and viral replication generating new tumor cells. In addition, the B complex controls tumor growth induced by a subviral DNA construct encoding only the RSV v-src oncogene. Immunity to subsequent tumors and metastasis also exhibit MHC control. Genotypes that regressed either RSV or v-src DNA primary tumors had enhanced protection against subsequent homologous challenge. Regressor B genotypes had lower tumor metastasis compared with progressor types. Together, the data indicate that B complex control of RSV tumor fate is strongly defined by the response to a v-src-determined function. Differential RSV tumor outcomes among various B genotypes may include immune recognition of a tumor-specific antigen or immune system influences on viral replication.
Asunto(s)
Virus del Sarcoma Aviar/inmunología , Complejo Mayor de Histocompatibilidad/inmunología , Enfermedades de las Aves de Corral/inmunología , Sarcoma Aviar/inmunología , Animales , Virus del Sarcoma Aviar/clasificación , Pollos , Cruzamientos Genéticos , Femenino , Dosificación de Gen , Masculino , Enfermedades de las Aves de Corral/genética , Enfermedades de las Aves de Corral/patología , Sarcoma Aviar/genética , Sarcoma Aviar/patologíaRESUMEN
Selection for disease resistance related traits is a tool of choice for evidencing and exploring genetic variability and studying underlying resistance mechanisms. In this framework, chickens originating from a base population, homozygote for the B19 major histocompatibility complex (MHC) were divergently selected for either progression or regression of tumors induced at 4 weeks of age by a SR-D strain of Rous sarcoma virus (RSV). The first generation of selection was based on a progeny test and subsequent selections were performed on full-sibs. Data of 18 generations including a total of 2010 birds measured were analyzed for the tumor profile index (TPI), a synthetic criterion of resistance derived from recording the volume of the tumors and mortality. Response to selection and heritability of TPI were estimated using a restricted maximum likelihood method with an animal model. Significant progress was shown in both directions: the lines differing significantly for TPI and mortality becoming null in the "regressor" line. Heritability of TPI was estimated as 0.49 +/- 0.05 and 0.53 +/- 0.06 within the progressor and regressor lines respectively, and 0.46 +/- 0.03 when estimated over lines. Preliminary results showed within the progressor line a possible association between one Rfp-Y type and the growth of tumors.
Asunto(s)
Virus del Sarcoma Aviar/inmunología , Pollos/virología , Inmunidad Innata/genética , Sarcoma Aviar/inmunología , Selección Genética , Animales , Pollos/genética , Pollos/inmunología , Interpretación Estadística de Datos , Inmunidad Innata/inmunología , Análisis de los Mínimos Cuadrados , Complejo Mayor de Histocompatibilidad/genética , Complejo Mayor de Histocompatibilidad/inmunología , FenotipoRESUMEN
B(12) haplotype of the inbred chicken line CB (B12/B12) contains, like the bulk of chicken MHC(B) haplotypes, only a single dominantly expressed class I molecule (B-F). The peptide binding motifs for this major B-F12 molecule in chickens of Rous sarcoma regressor line CB (B12/B12) have been determined. Using stringent and relaxed motifs, several peptides were found in the v-src molecule of the PR-RSV-C, but most of these peptides are identical with that of endogenous c-src. Only the v-src C-tail peptide(517-524) (LPACVLEV) contains critical anchor amino acids (valine at positions 5 and 8) and shows a sequence different from the corresponding c-src peptide. This v-src C-tail peptide up-regulates expression of the B-F12 class I molecule on PBL, as assessed by FACS analysis, and stimulates T cell proliferation in a [3H]thymidine uptake assay. A protective effect of the immune response to LPACVLEV against RSV challenge was demonstrated in CB (B12/B12) chickens immunised with peptides encapsulated in liposomes.
Asunto(s)
Virus del Sarcoma Aviar , Vacunas contra el Cáncer/inmunología , Antígenos de Histocompatibilidad Clase I/biosíntesis , Proteína Oncogénica pp60(v-src)/inmunología , Fragmentos de Péptidos/inmunología , Sarcoma Aviar/prevención & control , Alelos , Animales , División Celular , Pollos , Haplotipos , Antígenos de Histocompatibilidad Clase I/genética , Antígenos de Histocompatibilidad Clase I/inmunología , Liposomas , Microesferas , Proteína Oncogénica pp60(v-src)/genética , Sarcoma Aviar/inmunología , Sarcoma Aviar/virología , Regulación hacia Arriba , Vacunación/veterinariaRESUMEN
This study was designed to examine the alloantigen system L effects on Rous sarcomas in three B complex genotypes. The parental stock was 50% Modified Wisconsin Line 3 x White Leghorn Line NIU 4 and 50% inbred Line 6.15-5. Pedigree matings of two B(2)B(5) L(1)L(2) sires to five B(2)B(5) L(1)L(2) dams per sire produced experimental chicks segregating for B and L genotypes. Chicks were inoculated with 20 pock-forming units (pfu) of Rous sarcoma virus (RSV) at 6 weeks of age. Tumors were scored six times over 10 weeks postinoculation after which the tumor scores were used to assign a tumor profile index (TPI) to each chicken. Tumor growth over time and TPI were evaluated by repeated-measures analysis of variance and analysis of variance, respectively. Six trials were conducted with a total of 151 chickens. The major histocompatibility (B) complex affected the responses as the B(2)B(2) and B(2)B(5) genotypes had significantly lower tumor growth over time and TPI than the B(5)B(5) genotype. Separate analyses revealed no significant L system effect in B(2)B(2) or B(2)B(5) backgrounds. However, L genotype significantly affected (P < 0.05) both tumor growth over time and TPI in B(5)B(5) chickens. B(5)B(5) L(1)L(2) birds had TPI significantly lower than B(5)B(5) L(1)L(1) chickens but not B(5)B(5) L(2)L(2). Mortality was lower in the B(5)B(5) L(1)L(2) birds than in B(5)B(5) L(2)L(2) chickens. The L system, or one closely linked, affects the growth and ultimate outcome of Rous sarcomas. The response may depend upon the genetic background as well as MHC type.
Asunto(s)
Pollos , Antígenos de Histocompatibilidad/inmunología , Sarcoma Aviar/inmunología , Animales , Predisposición Genética a la Enfermedad , Haplotipos , Antígenos de Histocompatibilidad/genética , Pronóstico , Sarcoma Aviar/genética , Sarcoma Aviar/mortalidad , Sarcoma Aviar/fisiopatologíaRESUMEN
DNA vaccination is particularly efficient for induction of cytotoxic T-lymphocyte (CTL) response. In our experiments, we used MHC(B) congenic chicken lines CB and CC (regressors and progressors of v-src-induced tumours, respectively) and a mutated, non-oncogenic v-src gene construct as the DNA vaccine. A high degree of vaccine protection against oncogenic v-src challenge was achieved in the CB line chickens. CTL response was demonstrated in vitro and by adoptive transfer of immune cells to the syngeneic host and to the CC line chickens rendered tolerant to CB cells. In the CC line chickens we observed tumour growth retardation after a low-dose DNA vaccination administered to immature recipients while higher amounts of DNA vaccine in immunocompetent chickens exerted an enhancing effect.
Asunto(s)
Virus del Sarcoma Aviar/inmunología , Genes src/inmunología , Proteína Oncogénica pp60(v-src)/inmunología , Sarcoma Aviar/inmunología , Sarcoma Aviar/prevención & control , Vacunas de ADN/uso terapéutico , Vacunas Virales/uso terapéutico , Traslado Adoptivo/métodos , Factores de Edad , Animales , Animales Congénicos , Virus del Sarcoma Aviar/genética , Transformación Celular Viral , Embrión de Pollo , Pollos , Relación Dosis-Respuesta Inmunológica , Genes src/genética , Vacunas Virales/genéticaRESUMEN
Rous sarcoma virus-induced tumor outcome is controlled by the MHC (B). Additional data, using controlled segregation in families, has indicated non-MHC effects as well, but few studies have focused on blood groups other than the B complex. Segregating combinations of genes encoding erythrocyte (Ea) alloantigen systems A, C, D, E, H, I, P, and L in B2B5 and B5B5 MHC (B) backgrounds were examined for their effects on Rous sarcomas. Six-week-old chickens were inoculated in the wing-web with 30 pfu of Rous sarcoma virus (RSV). Tumors were scored six times over a 10-wk period. A tumor profile index (TPI) was assigned to each chicken based on the six tumor size scores. Response was evaluated using tumor size at each measurement period, TPI, and mortality. The genotypes of Ea systems A, C, D, E, H, I, and P had no significant effect on any parameter in either B complex population. The Ea-L system had an effect on Rous sarcomas in the B2B5 intermediate responders and B5B5 progressors. Tumor size, TPI, and mortality were all significantly lower in B2B5 L1L1 chickens than in B2B5 L1L2 chickens. Mortality was lower in the B5B5 L1L1 birds than in B5B5 L1L2 chickens. It appears that the Ea-L system, or one closely linked, is acting in a manner independent of the B complex in response to RSV challenge.
Asunto(s)
Virus del Sarcoma Aviar/inmunología , Pollos/virología , Isoantígenos/inmunología , Sarcoma Aviar/inmunología , Animales , Virus del Sarcoma Aviar/patogenicidad , Pollos/inmunología , Femenino , Masculino , Mortalidad , Sarcoma Aviar/patologíaRESUMEN
In contrast to the major histocompatibility complex (MHC) of well-studied mammals such as humans and mice, the particular haplotype of the B-F/B-L region of the chicken B locus determines life and death in response to certain infectious pathogens as well as to certain vaccines. We found that the B-F/B-L region is much smaller and simpler than the typical mammalian MHC, with an important difference being the expression of a single class I gene at a high level of RNA and protein. The peptide-binding specificity of this dominantly expressed class I molecule in different haplotypes correlates with resistance to tumours caused by Rous sarcoma virus, while the cell-surface expression level correlates with susceptibility to tumours caused by Marek's disease virus. A similar story is developing with class II beta genes and response to killed viral vaccines. This apparently suicidal strategy of single dominantly expressed class I and class II molecules may be due to coevolution between genes within the compact chicken MHC.
Asunto(s)
Pollos/genética , Pollos/inmunología , Predisposición Genética a la Enfermedad , Complejo Mayor de Histocompatibilidad , Vacunas Virales/inmunología , Animales , Virus del Sarcoma Aviar/patogenicidad , Herpesvirus Gallináceo 2/patogenicidad , Enfermedad de Marek/genética , Enfermedad de Marek/inmunología , Sarcoma Aviar/genética , Sarcoma Aviar/inmunologíaRESUMEN
Growth of tumors induced by Rous sarcoma virus (RSV) is controlled by alleles at the major histocompatibility complex locus in chickens, indicating that immunological host defense mechanisms play a major role. We show here that the resistance phenotype of CB regressor chickens can be partially reverted by treating the animals with a monoclonal antibody that neutralizes the major serotype of chicken type I interferon, ChIFN-alpha. Injection of recombinant ChIFN-alpha into susceptible CC progressor chickens resulted in a dose-dependent inhibition of RSV-induced tumor development. This treatment was not effective, however, in CC chickens challenged with a DNA construct expressing the v-src oncogene, suggesting that the beneficial effect of type I interferon in this system resulted from its intrinsic antiviral activity and probably not from indirect immunmodulatory effects. By contrast, recombinant chicken interferon-gamma strongly inhibited tumor growth when given to CC chickens that were challenged with the v-src oncogene, indicating that the two cytokines target different steps of tumor development.
Asunto(s)
Virus del Sarcoma Aviar/patogenicidad , Genes src , Interferón Tipo I/uso terapéutico , Sarcoma Aviar/prevención & control , Animales , Virus del Sarcoma Aviar/genética , Línea Celular , Pollos , Coturnix , ADN Viral/genética , Interferón gamma/uso terapéutico , Proteínas Recombinantes , Sarcoma Aviar/inmunología , Sarcoma Aviar/patología , Factores de Tiempo , TransfecciónRESUMEN
A study using two high-performance broiler lines, a synthetic male line (SML) and a synthetic dam line (SDL), was undertaken to investigate the pattern of mortality due to induced liver tumours (LT) and the immune response to subgroup A virus inoculated via the chorioallantoic membrane (CAM) route. The distribution patterns of the four possible phenotypes were similar in both sire and dam lines. The occurrence of conversely associated phenotypes was about 30S, in both the lines. The percentages of CAM(+) LT(-) and CAM(-) LT(+) were 14.26%, and 14.46% in the dam line and 20.0% and 9.57% in the male line. The LT mortality was 30-50% in the birds with low pock counts, whereas it was 80-93% in the birds with high pock counts. The group specific antigen shedding status did not influence death due to LT. In birds in the high pock count group, 98% of deaths due to LT were completed by the sixth week, whereas in those in the low pock count group, death due to LT was spread over 24 weeks. The SDL birds survived better than SML birds in the high pock count groups. In both lines, about 20% of deaths occurred owing to non-specific causes. The average survival time after hatching before death from LT was 26 days, whereas that for non-specific death was 81 days.